(CRI) Carter’s - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1462291097
Apparel, Footwear, Accessories, Home Gear, Bedding
Dividends
| Dividend Yield | 4.86% |
| Yield on Cost 5y | 2.10% |
| Yield CAGR 5y | 51.97% |
| Payout Consistency | 94.2% |
| Payout Ratio | 39.1% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 53.5% |
| Value at Risk 5%th | 84.3% |
| Relative Tail Risk | -4.22% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.64 |
| Alpha | -58.77 |
| CAGR/Max DD | -0.29 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.353 |
| Beta | 1.294 |
| Beta Downside | 0.797 |
| Drawdowns 3y | |
|---|---|
| Max DD | 71.26% |
| Mean DD | 29.33% |
| Median DD | 22.28% |
Description: CRI Carter’s November 14, 2025
Carter’s, Inc. (NYSE:CRI) designs, sources, and markets a portfolio of children’s apparel and related products-including Carter’s, OshKosh B’gosh, Skip Hop, and several licensed lines-across three operating segments: U.S. Retail, U.S. Wholesale, and International.
The company’s core offerings span baby and toddler basics (bodysuits, sleepwear, dresses) and play-time apparel (denim, overalls, knit tops) under the Carter’s and OshKosh brands, while the Skip Hop brand supplies bags, bedding, and accessories. Sales are generated through a mix of wholesale partners (department stores, specialty chains), company-owned retail locations, and direct-to-consumer channels such as carters.com, oshkosh.com, skiphop.com, and a mobile app.
Key recent metrics: FY2023 net revenue reached approximately $4.3 billion, with comparable-sales growth of 5% YoY driven largely by a 15% surge in e-commerce sales. The business benefits from a relatively low-price elasticity segment, as infant apparel demand is historically resilient to macro-economic cycles, while overall U.S. consumer discretionary spending and birth-rate trends remain primary drivers of top-line performance.
For a deeper, data-driven look at Carter’s valuation and peer benchmarks, the ValueRay platform provides a concise, analytics-focused overview.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (89.1m TTM) > 0 and > 6% of Revenue (6% = 170.0m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -7.95pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 22.31% (prev 20.67%; Δ 1.65pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 151.2m > Net Income 89.1m (YES >=105%, WARN >=100%) |
| Net Debt (994.2m) to EBITDA (199.5m) ratio: 4.98 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.26 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (35.4m) change vs 12m ago 0.40% (target <= -2.0% for YES) |
| Gross Margin 46.79% (prev 48.28%; Δ -1.49pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 116.9% (prev 119.5%; Δ -2.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.66 (EBITDA TTM 199.5m / Interest Expense TTM 31.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.79
| (A) 0.26 = (Total Current Assets 1.13b - Total Current Liabilities 501.7m) / Total Assets 2.47b |
| (B) 0.35 = Retained Earnings (Balance) 874.4m / Total Assets 2.47b |
| (C) 0.06 = EBIT TTM 144.7m / Avg Total Assets 2.42b |
| (D) 0.53 = Book Value of Equity 846.6m / Total Liabilities 1.60b |
| Total Rating: 3.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 48.32
| 1. Piotroski 2.50pt |
| 2. FCF Yield 4.52% |
| 3. FCF Margin 3.25% |
| 4. Debt/Equity 1.36 |
| 5. Debt/Ebitda 4.98 |
| 6. ROIC - WACC (= 3.05)% |
| 7. RoE 10.42% |
| 8. Rev. Trend -46.30% |
| 9. EPS Trend -51.96% |
What is the price of CRI shares?
As of December 01, 2025, the stock is trading at USD 31.91 with a total of 381,117 shares traded.
Over the past week, the price has changed by +6.37%, over one month by +2.08%, over three months by +13.70% and over the past year by -38.82%.
Over the past week, the price has changed by +6.37%, over one month by +2.08%, over three months by +13.70% and over the past year by -38.82%.
Is CRI a buy, sell or hold?
Carter’s has received a consensus analysts rating of 2.33.
Therefor, it is recommend to sell CRI.
- Strong Buy: 0
- Buy: 0
- Hold: 3
- Sell: 2
- Strong Sell: 1
What are the forecasts/targets for the CRI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.5 | -7.6% |
| Analysts Target Price | 29.5 | -7.6% |
| ValueRay Target Price | 30.1 | -5.8% |
CRI Fundamental Data Overview November 20, 2025
Market Cap USD = 1.04b (1.04b USD * 1.0 USD.USD)
P/E Trailing = 11.6016
P/E Forward = 13.587
P/S = 0.3672
P/B = 1.2874
P/EG = 1.81
Beta = 1.079
Revenue TTM = 2.83b USD
EBIT TTM = 144.7m USD
EBITDA TTM = 199.5m USD
Long Term Debt = 498.7m USD (from longTermDebt, last quarter)
Short Term Debt = 150.5m USD (from shortTermDebt, last quarter)
Debt = 1.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 994.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.03b USD (1.04b + Debt 1.18b - CCE 184.2m)
Interest Coverage Ratio = 4.66 (Ebit TTM 144.7m / Interest Expense TTM 31.0m)
FCF Yield = 4.52% (FCF TTM 92.0m / Enterprise Value 2.03b)
FCF Margin = 3.25% (FCF TTM 92.0m / Revenue TTM 2.83b)
Net Margin = 3.15% (Net Income TTM 89.1m / Revenue TTM 2.83b)
Gross Margin = 46.79% ((Revenue TTM 2.83b - Cost of Revenue TTM 1.51b) / Revenue TTM)
Gross Margin QoQ = 45.08% (prev 48.14%)
Tobins Q-Ratio = 0.82 (Enterprise Value 2.03b / Total Assets 2.47b)
Interest Expense / Debt = 0.61% (Interest Expense 7.17m / Debt 1.18b)
Taxrate = 21.85% (3.24m / 14.8m)
NOPAT = 113.1m (EBIT 144.7m * (1 - 21.85%))
Current Ratio = 2.26 (Total Current Assets 1.13b / Total Current Liabilities 501.7m)
Debt / Equity = 1.36 (Debt 1.18b / totalStockholderEquity, last quarter 864.6m)
Debt / EBITDA = 4.98 (Net Debt 994.2m / EBITDA 199.5m)
Debt / FCF = 10.81 (Net Debt 994.2m / FCF TTM 92.0m)
Total Stockholder Equity = 855.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.61% (Net Income 89.1m / Total Assets 2.47b)
RoE = 10.42% (Net Income TTM 89.1m / Total Stockholder Equity 855.1m)
RoCE = 10.69% (EBIT 144.7m / Capital Employed (Equity 855.1m + L.T.Debt 498.7m))
RoIC = 8.35% (NOPAT 113.1m / Invested Capital 1.35b)
WACC = 5.31% (E(1.04b)/V(2.22b) * Re(10.78%) + D(1.18b)/V(2.22b) * Rd(0.61%) * (1-Tc(0.22)))
Discount Rate = 10.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.77%
[DCF Debug] Terminal Value 65.71% ; FCFE base≈166.2m ; Y1≈142.1m ; Y5≈110.2m
Fair Price DCF = 36.51 (DCF Value 1.33b / Shares Outstanding 36.4m; 5y FCF grow -17.63% → 3.0% )
EPS Correlation: -51.96 | EPS CAGR: -26.18% | SUE: 0.11 | # QB: 0
Revenue Correlation: -46.30 | Revenue CAGR: -8.61% | SUE: -1.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.26 | Chg30d=+0.126 | Revisions Net=+2 | Analysts=4
EPS current Year (2025-12-31): EPS=2.95 | Chg30d=-0.169 | Revisions Net=+0 | Growth EPS=-49.3% | Growth Revenue=+0.5%
EPS next Year (2026-12-31): EPS=2.40 | Chg30d=+0.153 | Revisions Net=+1 | Growth EPS=-18.7% | Growth Revenue=-0.4%
P/E Trailing = 11.6016
P/E Forward = 13.587
P/S = 0.3672
P/B = 1.2874
P/EG = 1.81
Beta = 1.079
Revenue TTM = 2.83b USD
EBIT TTM = 144.7m USD
EBITDA TTM = 199.5m USD
Long Term Debt = 498.7m USD (from longTermDebt, last quarter)
Short Term Debt = 150.5m USD (from shortTermDebt, last quarter)
Debt = 1.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 994.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.03b USD (1.04b + Debt 1.18b - CCE 184.2m)
Interest Coverage Ratio = 4.66 (Ebit TTM 144.7m / Interest Expense TTM 31.0m)
FCF Yield = 4.52% (FCF TTM 92.0m / Enterprise Value 2.03b)
FCF Margin = 3.25% (FCF TTM 92.0m / Revenue TTM 2.83b)
Net Margin = 3.15% (Net Income TTM 89.1m / Revenue TTM 2.83b)
Gross Margin = 46.79% ((Revenue TTM 2.83b - Cost of Revenue TTM 1.51b) / Revenue TTM)
Gross Margin QoQ = 45.08% (prev 48.14%)
Tobins Q-Ratio = 0.82 (Enterprise Value 2.03b / Total Assets 2.47b)
Interest Expense / Debt = 0.61% (Interest Expense 7.17m / Debt 1.18b)
Taxrate = 21.85% (3.24m / 14.8m)
NOPAT = 113.1m (EBIT 144.7m * (1 - 21.85%))
Current Ratio = 2.26 (Total Current Assets 1.13b / Total Current Liabilities 501.7m)
Debt / Equity = 1.36 (Debt 1.18b / totalStockholderEquity, last quarter 864.6m)
Debt / EBITDA = 4.98 (Net Debt 994.2m / EBITDA 199.5m)
Debt / FCF = 10.81 (Net Debt 994.2m / FCF TTM 92.0m)
Total Stockholder Equity = 855.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.61% (Net Income 89.1m / Total Assets 2.47b)
RoE = 10.42% (Net Income TTM 89.1m / Total Stockholder Equity 855.1m)
RoCE = 10.69% (EBIT 144.7m / Capital Employed (Equity 855.1m + L.T.Debt 498.7m))
RoIC = 8.35% (NOPAT 113.1m / Invested Capital 1.35b)
WACC = 5.31% (E(1.04b)/V(2.22b) * Re(10.78%) + D(1.18b)/V(2.22b) * Rd(0.61%) * (1-Tc(0.22)))
Discount Rate = 10.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.77%
[DCF Debug] Terminal Value 65.71% ; FCFE base≈166.2m ; Y1≈142.1m ; Y5≈110.2m
Fair Price DCF = 36.51 (DCF Value 1.33b / Shares Outstanding 36.4m; 5y FCF grow -17.63% → 3.0% )
EPS Correlation: -51.96 | EPS CAGR: -26.18% | SUE: 0.11 | # QB: 0
Revenue Correlation: -46.30 | Revenue CAGR: -8.61% | SUE: -1.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.26 | Chg30d=+0.126 | Revisions Net=+2 | Analysts=4
EPS current Year (2025-12-31): EPS=2.95 | Chg30d=-0.169 | Revisions Net=+0 | Growth EPS=-49.3% | Growth Revenue=+0.5%
EPS next Year (2026-12-31): EPS=2.40 | Chg30d=+0.153 | Revisions Net=+1 | Growth EPS=-18.7% | Growth Revenue=-0.4%
Additional Sources for CRI Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle